ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Neuro-Oncologist Schold Leaves Duke For UPCI; Rosner Leads Institute At Chicago.

September 1, 2000

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

In Brief: Harold Douglass New GITSG Chairman: NTP Deputy Chief Moore to Be Nominated For Top EPA Position

August 5, 1983